BPC-157 has a very high safety profile in terms of lethal dosing, with an LD50 as high as 2 grams (2,000 mg) per kilogram of body weight; typical therapeutic doses are far lower, around 300-500 micrograms subcutaneously two to three times per week for about 8 weeks, followed by cycling off for 8-10 weeks.
factualpending
Speaker
Andrew HubermanEvidence Quote
“The typical therapeutic doses that are prescribed are anywhere from 300 to 500 micrograms subcutaneously, maybe two or three times per week. And that is typically done for a course of about 8 weeks, and then people typically cycle off for anywhere from 8 to 10 weeks.”
Created: 6/18/2026, 1:57:48 PM
My Notes
Loading notes...